/Investor DB

Brain Trust Accelerator Fund — Full Portfolio

3 tracked investments · listed companies and verified rows first

Neurotherapianeurotherapia.comin✓ verified

NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US

Co-investorsDolby Family Ventures

BrainScopebrainscope.comSep 2010SEC filinghigh confidence

BrainScope is a neurotechnology company that turns EEG brain electrical activity into objective diagnostic biomarkers using machine and deep learning for assessing head injuries, concussion, and other brain conditions.

AI & Machine LearningDigital HealthHealthtechMedical DevicesBethesda, US

Michael E. Singer(Executive Officer, Director)inKerstin Schultz(Executive Officer)Laurie Silver(President (former CEO, CFO, CAO))Matt Adams(Chief Executive Officer)Leslie S. Prichep(Chief Scientific Officer)

BoardJean Case(Director)

Board seatJohn M. Reher· per SEC Form D · $16.5M raise · filed Sep 2015

Co-investorsDBL PartnersRevolution

CHASE Pharmaceuticalschasepharmaceuticals.comJan 2016SEC filingmedium confidence

Irvine, CA based Alzheimer's drug company

BiotechWashington, US

Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)John M. Siebert(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)

BoardNayan Greg Parekh(Director)

Board seatJohn M. Reher· per SEC Form D · $612.5K raise · filed Feb 2016

Co-investorsAndera PartnersNew Rhein Healthcare Investors, LLC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.